Skip to main content
. 2012 Apr;58(4):389–393.

Figure 3.

Figure 3

Pharmacologic interventions to reduce CMR

BP—blood pressure, CDA—Canadian Diabetes Association, CHEP—Canadian Hypertension Education Program, CKD—chronic kidney disease, CMR—cardiometabolic risk, CPG—clinical practice guidelines, CRP—C-reactive protein, DM—diabetes mellitus, HbA1c—hemoglobin A1c, LDL-C—low-density lipoprotein cholesterol.